Skip to content

Olav Spigset

2 papers in the library · publishing 1999-2008

Papers

Sort Most recent Most cited

The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.

Basic & Clinical Pharmacology & Toxicology January 2008 Sunniva Nyberg Karlsen, Olav Spigset, Lars Slørdal

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a known neurotoxin in animals. This review discusses the history, pattern of use, pharmacology, acute and long-term effects of MDMA. Emphasis is given to the concern that MDMA may induce long-term cognitive and psychiatric effects. MDMA is an illegal substance, and investigations of the effects of exposure in human beings have limitations and...

Binding of [3H]lysergic Acid Diethylamide to Serotonin 5-HT2A Receptors and of [3H]paroxetine to Serotonin Uptake Sites in Platelets from Healthy Children, Adolescents and Adults

Neuropsychobiology 1999 Jeanette Sigurdh, Olav Spigset, Per O. Allard et al.

Possible age effects on binding of [3H]lysergic acid diethylamide ([3H]LSD) to serotonin 5-HT2A receptors and of [3H]paroxetine to serotonin uptake sites were studied in platelets from healthy children (11–12 years of age), adolescents (16–17 years of age) and adults. Significant overall age effects were found both for the number of binding sites (Bmax) for [3H]LSD binding (p < 0.001), the...